Sae-Ryung Kang / M.D.
· Position : Assistant Professor, Department of Nuclear Medicine, Chonnam National University Hwasun Hospital
· Interesting field : Cancer Imaging, Infection Imaging, Pain Imaging
Tel+82-61-379-7267
E-mailcampanella9@naver.com
Education
- 2016 - Present: Ph.D. student, Chonnam National University Medical School
- 2010 - 2012: M.S., Chonnam National University Medical School
- 2002 - 2008: B.S., Chonnam National University Medical School
- 2010 - 2012: M.S., Chonnam National University Medical School
- 2002 - 2008: B.S., Chonnam National University Medical School
Experience
- 2022.5 - present: Clinical associate professor, Department of Nuclear Medicine, Chonnam National University Hwasun Hospital
- 2018 - 2022.4: Clinical assistant professor, Department of Nuclear Medicine, Chonnam National University Hwasun Hospital
- 2015 - 2017: Instructor, Department of Nuclear Medicine, Chonnam National University Hwasun Hospital
- 2014: Clinical fellow, Department of Nuclear Medicine, Chonnam National University Hospital
- 2012.6: Visiting Physician, Department of Nuclear Medicine, University of Texas MD Anderson Cancer Center
- 2010 - 2013: Resident, Department of Nuclear Medicine, Chonnam National University Hospital & Chonnam National University Hwasun Hospital
- 2018 - 2022.4: Clinical assistant professor, Department of Nuclear Medicine, Chonnam National University Hwasun Hospital
- 2015 - 2017: Instructor, Department of Nuclear Medicine, Chonnam National University Hwasun Hospital
- 2014: Clinical fellow, Department of Nuclear Medicine, Chonnam National University Hospital
- 2012.6: Visiting Physician, Department of Nuclear Medicine, University of Texas MD Anderson Cancer Center
- 2010 - 2013: Resident, Department of Nuclear Medicine, Chonnam National University Hospital & Chonnam National University Hwasun Hospital
Honors and Award
- 2021 Korean Society of Nuclear Medicine The Best Article Award
- 2020 Chonnam National University Hospital The Young Investigator Award
- 2017 Korean Society of Nuclear Medicine Best Poster Aword
- 2015 Korean Society of Nuclear Medicine Fusi Film Aword
- 2013 Korean Society of Nuclear Medicine Best Presentation Aword
- 2012 Korean Society of Nuclear Medicine Young Investigator
- 2020 Chonnam National University Hospital The Young Investigator Award
- 2017 Korean Society of Nuclear Medicine Best Poster Aword
- 2015 Korean Society of Nuclear Medicine Fusi Film Aword
- 2013 Korean Society of Nuclear Medicine Best Presentation Aword
- 2012 Korean Society of Nuclear Medicine Young Investigator
Academic Activity
- Member of World Molecular Imaging Society (WMIS)
- Member of Korean Society of Nuclear Medicine (KSNM) and Korean Society of Molecular Imaging (KSMI).
- Reviewer of Nuclear Medicine and Molecular Imaging (NMMI) and Korean Journal of Radiology (KJR).
- Member of Korean Society of Nuclear Medicine (KSNM) and Korean Society of Molecular Imaging (KSMI).
- Reviewer of Nuclear Medicine and Molecular Imaging (NMMI) and Korean Journal of Radiology (KJR).
Publications
- Molecular imaging approaches to facilitate bacteria-mediated cancer therapy. Advanced drug delivery reviews 2022;187:114366.
- Precise characterization of a solitary pulmonary nodule using tumor shadow disappearance rate-corrected F-18 FDG PET and enhanced CT. Medicine 2022;101:e28764.
- Bacteria and bacterial derivatives as delivery carriers for immunotherapy. Advanced drug delivery reviews 2021:114085.
- Differences in diagnostic impact of dual-tracer PET/computed tomography according to the extrahepatic metastatic site in patients with hepatocellular carcinoma. Nucl Med Commun 2021;42:685-93.
- Recent Progress in the Molecular Imaging of Tumor-Treating Bacteria. Nuclear medicine and molecular imaging 2021;55:7-14.
- Clinical Impact of F-18 FDG PET-CT on Biopsy Site Selection in Patients with Suspected Bone Metastasis of Unknown Primary Site. Nuclear medicine and molecular imaging 2020;54:192-8.
- Optimization of Predictive Performance for the Therapeutic Response Using Iodine Scan-Corrected Serum Thyroglobulin in Patients with Differentiated Thyroid Carcinoma. Cancers 2020;12.
- Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas. Annals of hematology 2020;99:83-91.
- Association of muscle and visceral adipose tissues with the probability of Alzheimer's disease in healthy subjects. Scientific reports 2019;9:949.
- Response Prediction of Altered Thyroglobulin Levels After Radioactive Iodine Therapy Aided by Recombinant Human Thyrotropin in Patients with Differentiated Thyroid Cancer. Nuclear medicine and molecular imaging. 2018;52:287-92.
- “The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer.” Eur J Nucl Med Mol Imaging. (2017) Epub ahead.
- “Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected 11C-methionine uptake.” EJNMMI Res. 2017; 7: 45. Published online 2017 May 23.
- “Correlation of Angina Pectoris and Perfusion Decrease by Collateral Circulation in Single-Vessel Coronary Chronic Total Occlusion Using Myocardial Perfusion Single-Photon Emission Computed Tomography.” Nucl Med Mol Imaging. 2016;50(1):54-62.
- “Brain Metastases Mimicking Hyperostosis Frontalis Interna on 99mTc-HDP Bone Scintigraphy.” Clin Nucl Med. 2016 Oct;41(10):789-91.
- “18F-FDG PET/CT Findings of Scrub Typhus.” Clin Nucl Med. 2015 Oct;40(10) :e484-5.
- “Stimulated Serum Thyroglobulin Level at the Time of First Dose of Radioactive Iodine Therapy Is the Most Predictive Factor for Therapeutic Failure in Patients With pillary thyroid Carcinoma.” Nucl Med Mol Imaging. 2014 Dec;48(4):255-61.
- “Clinical implication of F-18 FDG PET/CT in patients with secondary hemophagocytic lymphohistiocytosis.” Ann Hematol. 2014 Apr;93(4):661-7.
- “Intratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer.” Nucl Med Mol Imaging. 2014 Mar;48(1):16-25.
- “Prognostic Significance of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Operable Primary Breast Cancer.” Nucl Med Mol Imaging. 2012 Dec;46(4):278-85.
- “Herniation Pit Mimicking Osseous Metastasis on 18F-FDG PET/CT in Patient With Lung Cancer.” Clin Nucl Med. 2012 Jul;37(7):682-3.
- “The Clinical Usefulness of 18F-FDG PET/CT in Patients with Systemic Autoimmune Disease.” Nucl Med Mol Imaging. 2011 Sep; 45(3): 177–184.
- “Comparison of 131I whole-body imaging, 131I SPECT/CT, and 18F-FDG PET/CT in the detection of metastatic thyroid cancer.” Eur J Nucl Med Mol Imaging. 2011 Aug;38(8):1459-68.
- Precise characterization of a solitary pulmonary nodule using tumor shadow disappearance rate-corrected F-18 FDG PET and enhanced CT. Medicine 2022;101:e28764.
- Bacteria and bacterial derivatives as delivery carriers for immunotherapy. Advanced drug delivery reviews 2021:114085.
- Differences in diagnostic impact of dual-tracer PET/computed tomography according to the extrahepatic metastatic site in patients with hepatocellular carcinoma. Nucl Med Commun 2021;42:685-93.
- Recent Progress in the Molecular Imaging of Tumor-Treating Bacteria. Nuclear medicine and molecular imaging 2021;55:7-14.
- Clinical Impact of F-18 FDG PET-CT on Biopsy Site Selection in Patients with Suspected Bone Metastasis of Unknown Primary Site. Nuclear medicine and molecular imaging 2020;54:192-8.
- Optimization of Predictive Performance for the Therapeutic Response Using Iodine Scan-Corrected Serum Thyroglobulin in Patients with Differentiated Thyroid Carcinoma. Cancers 2020;12.
- Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas. Annals of hematology 2020;99:83-91.
- Association of muscle and visceral adipose tissues with the probability of Alzheimer's disease in healthy subjects. Scientific reports 2019;9:949.
- Response Prediction of Altered Thyroglobulin Levels After Radioactive Iodine Therapy Aided by Recombinant Human Thyrotropin in Patients with Differentiated Thyroid Cancer. Nuclear medicine and molecular imaging. 2018;52:287-92.
- “The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer.” Eur J Nucl Med Mol Imaging. (2017) Epub ahead.
- “Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected 11C-methionine uptake.” EJNMMI Res. 2017; 7: 45. Published online 2017 May 23.
- “Correlation of Angina Pectoris and Perfusion Decrease by Collateral Circulation in Single-Vessel Coronary Chronic Total Occlusion Using Myocardial Perfusion Single-Photon Emission Computed Tomography.” Nucl Med Mol Imaging. 2016;50(1):54-62.
- “Brain Metastases Mimicking Hyperostosis Frontalis Interna on 99mTc-HDP Bone Scintigraphy.” Clin Nucl Med. 2016 Oct;41(10):789-91.
- “18F-FDG PET/CT Findings of Scrub Typhus.” Clin Nucl Med. 2015 Oct;40(10) :e484-5.
- “Stimulated Serum Thyroglobulin Level at the Time of First Dose of Radioactive Iodine Therapy Is the Most Predictive Factor for Therapeutic Failure in Patients With pillary thyroid Carcinoma.” Nucl Med Mol Imaging. 2014 Dec;48(4):255-61.
- “Clinical implication of F-18 FDG PET/CT in patients with secondary hemophagocytic lymphohistiocytosis.” Ann Hematol. 2014 Apr;93(4):661-7.
- “Intratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer.” Nucl Med Mol Imaging. 2014 Mar;48(1):16-25.
- “Prognostic Significance of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Operable Primary Breast Cancer.” Nucl Med Mol Imaging. 2012 Dec;46(4):278-85.
- “Herniation Pit Mimicking Osseous Metastasis on 18F-FDG PET/CT in Patient With Lung Cancer.” Clin Nucl Med. 2012 Jul;37(7):682-3.
- “The Clinical Usefulness of 18F-FDG PET/CT in Patients with Systemic Autoimmune Disease.” Nucl Med Mol Imaging. 2011 Sep; 45(3): 177–184.
- “Comparison of 131I whole-body imaging, 131I SPECT/CT, and 18F-FDG PET/CT in the detection of metastatic thyroid cancer.” Eur J Nucl Med Mol Imaging. 2011 Aug;38(8):1459-68.